Abbvie Inc. vs Revolution Medicines, Inc.
ABBV vs RVMD — side-by-side comparison from reported financials. ABBV leads 4, RVMD leads 2 of 6 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Revolution Medicines, Inc.
RVMD · Healthcare
$189.76+0.87%Mixed
| Metric | ABBV | RVMD |
|---|---|---|
| Price | $276.43 | $189.76 |
| Market cap | $488B | $40.7B |
| Revenue (TTM) | $64.4B | $0 |
| Revenue growth | +1.8% | — |
| Net margin | 9.8% | — |
| Free cash flow | $18.2B | -$2.65B |
| Net cash (debt) | ($56.2B) | $2.75B |
| 1-year price return | +19.8% | +298.5% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | — |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | -54% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 3 of 11 |
| Employees | 57,000 | 883 |
Full résumé-style profiles: ABBV CV · RVMD CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.